Elsevier

Sleep Medicine

Volume 77, January 2021, Pages 270-278
Sleep Medicine

Original Article
Effect of repetitive transcranial magnetic stimulation on the cognitive impairment induced by sleep deprivation: a randomized trial

https://doi.org/10.1016/j.sleep.2020.06.019Get rights and content

Highlights

  • 24 hours of sleep deprivation (SD) induced cognitive impairment.

  • HF-rTMS administered during SD might help alleviate cognitive impairment by reversing the changes of the HPA axis, frontal activation and BDNF system.

  • Two sessions of rTMS may not alleviate emotional problems induced by SD.

Abstract

Objective

Currently, an efficient method for improving cognitive impairment due to sleep deprivation (SD) is lacking. The aim of this study is to evaluate the effect of high-frequency repetitive transcranial magnetic stimulation (rTMS) during SD on reversing the adverse effects of SD.

Methods

A total of 66 healthy people were randomized into the rTMS group and sham group. Both groups were deprived of sleep for 24 h. During SD, participants were asked to complete several cognitive tasks and underwent mood assessments. Saliva cortisol levels, plasma concentrations of brain-derived neurotrophic factor (BDNF), precursor BDNF (proBDNF), and tissue-type plasminogen activator (tPA), and frontal blood activation were detected before and after SD. The rTMS group received real rTMS stimulation for 2 sessions of 10 Hz rTMS (40 trains of 50 pulses with a 20-second intertrain interval) to the left dorsolateral prefrontal cortex and the sham group received sham stimulation during SD.

Results

Twenty-four hours of SD induced a reduced accuracy in the n-back task, increases in both anxiety and depression, increased cortisol levels, decreased frontal blood activation and decreased BDNF levels in healthy people. Notably, rTMS improved the hyperactivity of the hypothalamic-pituitary-adrenal axis and decreased frontal blood activation induced by SD, and reduced the consumption of plasma proBDNF.

Conclusions

Twenty-four hours of SD induced a cognitive impairment. The administration of high-frequency rTMS during sleep deprivation exerted positive effects on HPA axis and frontal activation and might help alleviate cognitive impairment in the long term.

Introduction

The problem of sleep deprivation (SD) has attracted widespread attention. From the perspective of individual health, SD is a major cause of a series of diseases, including increased risks of hypertension, diabetes, heart disease and stroke [1]. From a social perspective, SD also increases the incidence of traffic and medical accidents [2,3].

In neuroscience, SD exerts a negative effect on cognitive functions and mood. SD increases the variability in alertness, decreases attention, worsens moods, and decreases memory acquisition and consolidation [4,5].

Although previous studies have investigated the neurophysiological changes occurring within the body resulting from SD, the mechanism underlying the decrease in mood and performance induced by SD has not been clearly elucidated.

SD induces changes in brain metabolism and neural activation (eg, decreases in regional brain activation and cerebral blood flow) [6,7], and alterations in oxy-Hb and deoxy-Hb levels [8]. In addition, some studies have focused on biochemical changes occurring after SD.

The hypothalamic-pituitary-adrenal (HPA) axis plays an important role in regulating physiological responses to stress [9]. While SD affects the neuroendocrine stress systems, it potentially activates the HPA axis, which may induce cognitive impairment [10,11]. Cortisol levels in the blood and saliva increase after 24 h of SD, indicating the hyperactivity of the HPA axis [12,13]. Brain-derived neurotrophic factor (BDNF), a growth factor, plays an important role in synaptogenesis in brain regions. Its neurotrophic functions are relevant to neuroplasticity, memory and sleep [[14], [15], [16], [17]]. SD decreases BDNF levels, which leads to impairments in brain function [11].

As SD exerts many adverse effects, measures designed to maintain cognitive functions (eg, memory and attention) are of increasing importance. In recent years, some studies have investigated drugs and nonpharmacological methods to help people recover from SD [18], and because of the side effects of medication, the effect of noninvasive brain stimulation, such as repetitive transcranial magnetic stimulation (rTMS), on the cognitive impairment induced by SD has become a research hotspot.

Transcranial magnetic stimulation (TMS) is a neurostimulation and neuromodulation technique based on the principle of the electromagnetic induction of an electric field in the brain [19]. SD appears to induce relatively specific changes at the TMS level and therefore some TMS-derived measures of cortical excitability might be viewed both as electrocortical markers of SD and as targets for rTMS [20]. Currently, rTMS is described as a promising noninvasive intervention for people who have experienced SD. According to Luber and colleagues, high-frequency rTMS (HF-rTMS) facilitates the activation of brain regions in sleep-deprived individuals and reduces the SD-induced impairment in working memory [21,22], Meanwhile, another study also showed effects of HF-rTMS on ameliorating the cognitive impairment induced by SD [23]. Therefore, we chose a high frequency of 10 Hz for our study.

However, studies of the effect of rTMS on SD are still limited. The biochemical changes in individuals with SD treated with the rTMS intervention also remain unclear. The present study recruited healthy Chinese people to investigate the changes in cognitive function after SD and to evaluate the effects of rTMS on impaired cognitive function resulting from SD, as well as the mechanism of rTMS. We hypothesized that the application of HF-rTMS during SD might contribute to the recovery of the impaired cognitive function induced by SD.

Section snippets

Participants

This randomized, placebo-controlled, double-blind study was conducted between May 2018 and May 2019 in the Psychiatric Ward of the First Affiliated Hospital, Zhejiang University School of Medicine. On May 20, 2018, the participants were first recruited. The study was approved by the ethics committee of the First Affiliated Hospital of the Medical School of Zhejiang University in accordance with the Declaration of Helsinki (No. 2017631) and was registered in the China Clinical Trial Registry

Results

The two groups were matched by sex. No significant differences were detected in baseline data or demographic characteristics, including age and years of education, of the two groups (See Table 1).

Discussion

As shown in the present study, 24 h of SD impairs cognitive function, induces emotional disturbances, increases the activity of the HPA axis, decreases frontal activation and leads to dysfunction of the BDNF system. HF-rTMS applied to left DLPFC during SD reverses the hyperactivation of the HPA axis, reduced frontal activation and disturbances in the BDNF system. Based on these results, the SD-induced impairment in brain function might be ameliorated by HF-rTMS.

The present study evaluated the

Conclusions

In summary, SD leads to poor mood, impaired cognitive function, hyperactivation of the HPA axis, decreased frontal activation and abnormal function of the BDNF system. Importantly, HF-rTMS during SD reversed the overactivation of the HPA axis and reduced frontal activation. It might help alleviate the cognitive impairment in the long term.

Role of funding source

This work presented here was supported by the Major Subject of Zhejiang Province (grant number 2015C03040 to Yi Xu).

CRediT authorship contribution statement

Shangda Li: Investigation, Formal analysis, Writing - original draft, Writing - review & editing. Hetong Zhou: Validation, Writing - original draft. Yueran Yu: Data curation, Investigation. Hailong Lyu: Software, Writing - original draft. Tingting Mou: Investigation. Gongde Shi: Investigation. Shaohua Hu: Project administration, Writing - review & editing. Manli Huang: Project administration, Writing - review & editing. Jianbo Hu: Project administration, Writing - review & editing. Yi Xu:

Acknowledgement

We thank the participants for entering the experiment. We also thank the staff in the Department of Psychiatry of The First Affiliated Hospital, Zhejiang University School of Medicine for their assistance during the experiment. Finally, we thank Dr Lu Shaojia and Dr Yu Zhebin for kindly helping with the present study.

References (63)

  • A.R. Brunoni et al.

    Working memory improvement with non-invasive brain stimulation of the dorsolateral prefrontal cortex: a systematic review and meta-analysis

    Brain Cognit

    (2014)
  • T. Matsubara et al.

    Prefrontal activation in response to emotional words in patients with bipolar disorder and major depressive disorder

    Neuroimage

    (2014)
  • W. Quan et al.

    Reduced prefrontal activation during a verbal fluency task in Chinese-speaking patients with schizophrenia as measured by near-infrared spectroscopy

    Prog Neuro-Psychopharmacol Biol Psychiatry

    (2015)
  • Y. Zhu et al.

    Prefrontal activation during a working memory task differs between patients with unipolar and bipolar depression: a preliminary exploratory study

    J Affect Disord

    (2018)
  • P. Sagaspe et al.

    Effects of sleep deprivation on Color-Word, Emotional, and Specific Stroop interference and on self-reported anxiety

    Brain Cognit

    (2006)
  • L.B. Razza et al.

    A systematic review and meta-analysis on placebo response to repetitive transcranial magnetic stimulation for depression trials

    Prog Neuro-Psychopharmacol Biol Psychiatry

    (2018)
  • B. Jiang et al.

    Efficacy and placebo response of repetitive transcranial magnetic stimulation for primary insomnia

    Sleep Med

    (2019)
  • J.P. Lefaucheur et al.

    Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): an update (2014-2018)

    Clin Neurophysiol

    (2020)
  • J. Remue et al.

    Does a single neurostimulation session really affect mood in healthy individuals? A systematic review

    Neuropsychologia

    (2016)
  • B.L. Giacobbo et al.

    Could BDNF be involved in compensatory mechanisms to maintain cognitive performance despite acute sleep deprivation? An exploratory study

    Int J Psychophysiol

    (2016)
  • B. Luber et al.

    Enhancement of human cognitive performance using transcranial magnetic stimulation (TMS)

    Neuroimage

    (2014)
  • G. Leal et al.

    BDNF-induced local protein synthesis and synaptic plasticity

    Neuropharmacology

    (2014)
  • H. Harb et al.

    Assessment of Brain Derived Neurotrophic Factor in hair to study stress responses: a pilot investigation

    Psychoneuroendocrinology

    (2017)
  • Z. Wang et al.

    Antidepressant-like activity of resveratrol treatment in the forced swim test and tail suspension test in mice: the HPA axis, BDNF expression and phosphorylation of ERK

    Pharmacol Biochem Behav

    (2013)
  • J.M. Lyznicki et al.

    Sleepiness, driving, and motor vehicle crashes. Council on scientific affairs, American medical association

    JAMA

    (1998)
  • N. Goel et al.

    Neurocognitive consequences of sleep deprivation

    Semin Neurol

    (2009)
  • P. Maquet

    The role of sleep in learning and memory

    Science

    (2001)
  • N. Petrovsky et al.

    Sleep deprivation disrupts prepulse inhibition and induces psychosis-like symptoms in healthy humans

    J Neurosci

    (2014)
  • S. Banks et al.

    Chapter 5 - sleep deprivation

  • G.R. Poudel et al.

    Cerebral perfusion differences between drowsy and non drowsy individuals after acute sleep restriction

    Sleep

    (2012)
  • Cited by (11)

    • Transcutaneous auricular vagus stimulation (taVNS) improves human working memory performance under sleep deprivation stress

      2023, Behavioural Brain Research
      Citation Excerpt :

      Besides, some studies revealed that though caffeine could improve sustained attention impaired by SD, it did not elevate behavioral performance with a high cognitive load which is essential for occupational settings [12,15]. Therefore, some non-pharmacological methods, including transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), and transcranial magnetic stimulation (TMS) are promising [16–20]. These non-invasive electrical/magnetic neuromodulation devices can modulate the excitability of a range of cortical and subcortical regions and demonstrate significant potential in controlling cognition and regulating sleep [16,17].

    • Repetitive transcranial magnetic stimulation in primary sleep disorders

      2023, Sleep Medicine Reviews
      Citation Excerpt :

      The examination of the references from relevant papers did not detect additional articles fitting the purpose of this review. Therefore, a total of 27 papers were eventually included in the present review: 10 in primary CI [59–68], four in OSAS [69–72], five in RLS [73–77], five in SD [78–82], and three in other primary sleep disorders [83–85]. The main findings of rTMS studies in patients with primary CI are summarized in Table 1.

    View all citing articles on Scopus
    1

    Shangda Li and Hetong Zhou are co-first authors.

    View full text